SOPH
SOPHiA GENETICS SA
Latest Form 4:Sale$43KbyMenu Philippe (Chief Medical Officer) · filed Aug 26, 2026
SOPHiA GENETICS SA (SOPH) has 114 SEC Form 4 filings (160 transaction rows) in the rolling window, disclosed by 10 distinct insiders. Most recent filing: Aug 26, 2026.
The most active filer is Executive Chairman Camblong Jurgi with 25 filings. Insiders have net sold $4.0M over the trailing 6 months.
- Industry:Medical - Healthcare Information Services
- CEO:Ross Muken
- Employees:415
- HQ:Rolle, VD, CH
- IPO:2021-07-23
Insider Buying
$99K
reported purchases (SEC code P)
Insider Selling
$4.1M
reported sales (SEC code S)
Unique Insiders
10
in the rolling window
Market Cap
$610.9M
Price slightly stale
| Source | ||||||
|---|---|---|---|---|---|---|
| Chief Medical Officer | Sale | 5,000 | $43K | Aug 26 | SEC ↗ | |
HIBBS KATHY LFirst in 4 months | Director | Sale | 6,250 | $54K | Aug 26 | SEC ↗ |
| Chief Technology Officer | Sale | 5,000 | $41K | Aug 26 | SEC ↗ | |
| Chief Technology Officer | Sale | 5,000 | $44K | Aug 26 | SEC ↗ | |
| Chief Scientific Officer | Sale | 10,000 | $79K | Aug 21 | SEC ↗ | |
| Chief Scientific Officer | Sale | 4,592 | $39K | Aug 21 | SEC ↗ | |
| Chief Scientific Officer | Sale | 5,408 | $45K | Aug 21 | SEC ↗ | |
| Chief People Officer | Sale | 10,000 | $79K | Aug 21 | SEC ↗ | |
| Chief Scientific Officer | Sale | 4,000 | $30K | Aug 14 | SEC ↗ | |
| Chief Medical Officer | Sale | 5,000 | $38K | Aug 14 | SEC ↗ | |
| Chief Technology Officer | Sale | 5,000 | $38K | Aug 10 | SEC ↗ | |
| Executive Chairman | Sale | 20,000 | $145K | Aug 10 | SEC ↗ | |
| Executive Chairman | Sale | 8,500 | $65K | Aug 10 | SEC ↗ | |
| Chief Scientific Officer | Sale | 3,000 | $21K | Aug 7 | SEC ↗ | |
| Chief Scientific Officer | Sale | 17,000 | $124K | Aug 7 | SEC ↗ | |
| Chief Technology Officer | Sale | 5,000 | $35K | Aug 5 | SEC ↗ | |
| Chief Scientific Officer | Sale | 10,000 | $69K | Aug 5 | SEC ↗ | |
| Executive Chairman | Sale | 20,000 | $138K | Aug 5 | SEC ↗ | |
| Chief Medical Officer | Sale | 5,000 | $28K | Jul 28 | SEC ↗ | |
| Executive Chairman | Sale | 24,381 | $153K | Jul 22 | SEC ↗ | |
| Executive Chairman | Sale | 20,000 | $133K | Jul 22 | SEC ↗ | |
| Executive Chairman | Sale | 8,500 | $48K | Jul 14 | SEC ↗ | |
| Chief Medical Officer | Sale | 5,000 | $29K | Jul 14 | SEC ↗ | |
| Chief Scientific Officer | Sale | 4,000 | $23K | Jul 14 | SEC ↗ | |
| Executive Chairman | Sale | 17,685 | $93K | Jul 8 | SEC ↗ | |
| Chief Sales Officer | Sale | 216 | $1K | Jul 7 | SEC ↗ | |
| Chief People Officer | Sale | 4,241 | $21K | Jul 7 | SEC ↗ | |
| Executive Chairman | Sale | 22,486 | $118K | Jul 7 | SEC ↗ | |
| Chief Scientific Officer | Sale | 7,393 | $38K | Jul 7 | SEC ↗ | |
| Chief Technology Officer | Sale | 5,285 | $27K | Jul 7 | SEC ↗ | |
| Chief Medical Officer | Sale | 7,393 | $38K | Jul 7 | SEC ↗ | |
| Chief Executive Officer | Sale | 9,838 | $51K | Jul 7 | SEC ↗ | |
| Chief Financial Officer | Sale | 1,592 | $8K | Jul 7 | SEC ↗ | |
| Executive Chairman | Sale | 18,410 | $108K | Jul 1 | SEC ↗ | |
| Executive Chairman | Sale | 65,269 | $399K | Jul 1 | SEC ↗ | |
| Chief Executive Officer | Sale | 1,373 | $8K | Jun 29 | SEC ↗ | |
| Chief Executive Officer | Sale | 50,069 | $290K | Jun 29 | SEC ↗ | |
| Chief Technology Officer | Sale | 6,944 | $38K | Jun 26 | SEC ↗ | |
| Chief Medical Officer | Sale | 5,000 | $28K | Jun 26 | SEC ↗ | |
| Chief Financial Officer | Sale | 774 | $4K | Jun 23 | SEC ↗ | |
| President | Sale | 422 | $2K | Jun 23 | SEC ↗ | |
| Chief Scientific Officer | Sale | 4,000 | $20K | Jun 17 | SEC ↗ | |
| Chief Medical Officer | Sale | 5,000 | $25K | Jun 15 | SEC ↗ | |
| Chief Executive Officer | Sale | 8,500 | $45K | Jun 11 | SEC ↗ | |
| Chief Financial Officer | Purchase | 20,000 | $99K | Jun 5 | SEC ↗ | |
| Chief Medical Officer | Sale | 5,000 | $25K | Jun 1 | SEC ↗ | |
| Chief Legal Officer | Sale | 684 | $3K | May 20 | SEC ↗ | |
| Chief Executive Officer | Sale | 4,486 | $21K | May 20 | SEC ↗ | |
| Chief Scientific Officer | Sale | 608 | $3K | May 20 | SEC ↗ | |
| President | Sale | 761 | $4K | May 20 | SEC ↗ | |
| Chief People Officer | Sale | 380 | $2K | May 20 | SEC ↗ | |
| Chief Medical Officer | Sale | 608 | $3K | May 20 | SEC ↗ | |
| Chief Sales Officer | Sale | 33 | $150 | May 20 | SEC ↗ | |
| Chief Scientific Officer | Sale | 4,000 | $18K | May 14 | SEC ↗ | |
HIBBS KATHY LFirst filing | Director | Sale | 7,508 | $35K | May 13 | SEC ↗ |
| Chief Medical Officer | Sale | 5,000 | $23K | May 13 | SEC ↗ | |
| Chief Executive Officer | Sale | 8,500 | $43K | May 12 | SEC ↗ | |
| Chief Medical Officer | Sale | 5,000 | $24K | Apr 28 | SEC ↗ | |
| Chief Scientific Officer | Sale | 608 | $3K | Apr 21 | SEC ↗ | |
| Chief People Officer | Sale | 380 | $2K | Apr 21 | SEC ↗ | |
| President | Sale | 760 | $4K | Apr 21 | SEC ↗ | |
| Chief Legal Officer | Sale | 684 | $4K | Apr 21 | SEC ↗ | |
| Chief Executive Officer | Sale | 4,486 | $23K | Apr 21 | SEC ↗ | |
| Chief Medical Officer | Sale | 608 | $3K | Apr 21 | SEC ↗ | |
| Chief Sales Officer | Sale | 33 | $168 | Apr 21 | SEC ↗ | |
| Chief Executive Officer | Sale | 43,129 | $214K | Apr 16 | SEC ↗ | |
| Chief Executive Officer | Sale | 17,473 | $87K | Apr 16 | SEC ↗ | |
| Chief Medical Officer | Sale | 1,600 | $8K | Apr 16 | SEC ↗ | |
| Chief Scientific Officer | Sale | 600 | $3K | Apr 16 | SEC ↗ | |
| President | Sale | 2,800 | $14K | Apr 16 | SEC ↗ | |
| Chief Scientific Officer | Sale | 3,706 | $17K | Apr 14 | SEC ↗ | |
| Chief Scientific Officer | Sale | 4,414 | $21K | Apr 14 | SEC ↗ | |
| Chief Medical Officer | Sale | 3,725 | $17K | Apr 14 | SEC ↗ | |
| Chief Medical Officer | Sale | 4,400 | $21K | Apr 14 | SEC ↗ | |
| President | Sale | 3,687 | $17K | Apr 14 | SEC ↗ | |
| President | Sale | 4,442 | $21K | Apr 14 | SEC ↗ | |
| Chief Executive Officer | Sale | 12,232 | $58K | Apr 14 | SEC ↗ | |
| Chief Executive Officer | Sale | 4,399 | $21K | Apr 14 | SEC ↗ | |
| Chief Legal Officer | Sale | 2,400 | $11K | Apr 14 | SEC ↗ | |
| Chief Medical Officer | Sale | 2,800 | $14K | Apr 10 | SEC ↗ | |
| Chief Medical Officer | Sale | 1,931 | $9K | Apr 10 | SEC ↗ | |
| President | Sale | 2,786 | $13K | Apr 10 | SEC ↗ | |
| President | Sale | 1,950 | $9K | Apr 10 | SEC ↗ | |
| Chief Legal Officer | Sale | 2,861 | $14K | Apr 10 | SEC ↗ | |
| Chief Legal Officer | Sale | 1,988 | $9K | Apr 10 | SEC ↗ | |
| Chief Executive Officer | Sale | 2,800 | $14K | Apr 10 | SEC ↗ | |
| Chief Executive Officer | Sale | 1,950 | $9K | Apr 10 | SEC ↗ | |
| Chief Scientific Officer | Sale | 2,800 | $14K | Apr 10 | SEC ↗ | |
| Chief Scientific Officer | Sale | 1,936 | $9K | Apr 10 | SEC ↗ | |
| Chief Financial Officer | Sale | 1,403 | $7K | Apr 10 | SEC ↗ | |
| Chief People Officer | Sale | 3,824 | $19K | Apr 10 | SEC ↗ | |
| President | Sale | 2,600 | $13K | Apr 8 | SEC ↗ | |
| President | Sale | 2,424 | $12K | Apr 8 | SEC ↗ | |
| Chief Financial Officer | Sale | 2,520 | $12K | Apr 8 | SEC ↗ | |
| Chief Financial Officer | Sale | 2,413 | $12K | Apr 8 | SEC ↗ | |
| Chief Medical Officer | Sale | 2,700 | $13K | Apr 8 | SEC ↗ | |
| Chief Medical Officer | Sale | 2,400 | $12K | Apr 8 | SEC ↗ | |
| Chief Legal Officer | Sale | 2,705 | $13K | Apr 8 | SEC ↗ | |
| Chief Legal Officer | Sale | 2,400 | $12K | Apr 8 | SEC ↗ | |
| Chief Scientific Officer | Sale | 2,700 | $13K | Apr 8 | SEC ↗ | |
| Chief Scientific Officer | Sale | 2,400 | $12K | Apr 8 | SEC ↗ | |
Verma AbhimanyuFirst filing | Chief Technology Officer | Sale | 2,519 | $12K | Apr 8 | SEC ↗ |
Verma AbhimanyuFirst filing | Chief Technology Officer | Sale | 1,030 | $5K | Apr 8 | SEC ↗ |
| Chief Executive Officer | Sale | 2,600 | $13K | Apr 8 | SEC ↗ | |
| Chief Executive Officer | Sale | 2,500 | $12K | Apr 8 | SEC ↗ | |
| Chief People Officer | Sale | 2,597 | $13K | Apr 8 | SEC ↗ | |
| Chief People Officer | Sale | 2,376 | $12K | Apr 8 | SEC ↗ | |
| Chief Sales Officer | Sale | 624 | $3K | Apr 8 | SEC ↗ | |
| Chief Sales Officer | Sale | 3 | $14 | Apr 1 | SEC ↗ | |
Muken RossFirst filing | President | Sale | 1,183 | $6K | Mar 20 | SEC ↗ |
CARDOZA GEORGEFirst filing | Chief Financial Officer | Sale | 774 | $4K | Mar 20 | SEC ↗ |
Camblong JurgiFirst filing | Chief Executive Officer | Sale | 4,486 | $21K | Mar 20 | SEC ↗ |
Xu ZhenyuFirst filing | Chief Scientific Officer | Sale | 608 | $3K | Mar 20 | SEC ↗ |
Valente ManuelaFirst filing | Chief People Officer | Sale | 380 | $2K | Mar 20 | SEC ↗ |
Van Well DaanFirst filing | Chief Legal Officer | Sale | 684 | $3K | Mar 20 | SEC ↗ |
Menu PhilippeFirst filing | Chief Medical Officer | Sale | 608 | $3K | Mar 20 | SEC ↗ |
Puylaert KevinFirst filing | Chief Sales Officer | Sale | 33 | $157 | Mar 20 | SEC ↗ |
Related companies
SOPHiA GENETICS SA is in the Technology sector.